SCHEMBL24858705

SCHEMBL24858705

O=S1(=O)CCN(c2ccc(CNS)cc2)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.51
ALDH1A1 P00352 3/20 0.50
NCF1 P14598 1/20 0.43
WNT3A P56704 1/20 0.42
RORC P51449 2/20 0.41
ACHE P22303 1/20 0.41
KMT2A Q03164 3/20 0.40
MEN1 O00255 2/20 0.40
KLKB1 P03952 1/20 0.40
GAA P10253 5/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
PRMT5 O14744 1/20 0.38
WDR77 Q9BQA1 1/20 0.38
ACE2 Q9BYF1 1/20 0.37
MAPT P10636 3/20 0.37
ALOX15 P16050 3/20 0.37
ALOX12 P18054 3/20 0.37
GFER P55789 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20868507 0.85 NCF1 (0.60) KDM4EALDH1A1NCF1WNT3ARORC
SCHEMBL23059522 0.82 ALDH1A1 (0.50) KDM4EALDH1A1NCF1WNT3ARORC
SCHEMBL22358618 0.81 ALDH1A1 (0.49) KDM4EALDH1A1NCF1WNT3ARORC
SCHEMBL617426 0.81 KDM4E (0.58) KDM4EALDH1A1WNT3AKMT2AMEN1
SCHEMBL20868221 0.80 HTR2A (0.55) KDM4EALDH1A1WNT3AKMT2AMEN1
SCHEMBL12551052 0.79 KDM4E (0.54) KDM4EALDH1A1NCF1WNT3ARORC
SCHEMBL10066949 0.79 ALDH1A1 (0.57) KDM4EALDH1A1WNT3ARORCKMT2A
Hydrochloric Acid SCHEMBL20857074 0.77 KDM4E (0.53) KDM4EALDH1A1NCF1WNT3ARORC
SCHEMBL19245039 0.76 KDM4E (0.51) KDM4EALDH1A1WNT3ARORCKMT2A
SCHEMBL12551054 0.76 KDM4E (0.51) KDM4EALDH1A1WNT3ARORCKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230003706-A1 METHODS OF EVALUATING SMALL MOLECULE-MODIFIED POLYMERS IN COMPOSITIONS SIGILON THERAPEUTICS, INC. 2023-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230003706-A1 METHODS OF EVALUATING SMALL MOLECULE-MODIFIED POLYMERS IN COMPOSITIONS FN1, MFAP1, FIBP KDM4E 1950/4885ALDH1A1 3217/4885NCF1 2532/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.